|
Volumn 272, Issue 5270, 1996, Pages 1886-1888
|
HIV therapeutics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
ASPARTIC PROTEINASE;
CD4 ANTIGEN;
DIDANOSINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
LAMIVUDINE;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
CLINICAL TRIAL;
DRUG MIXTURE;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PHASE 3 CLINICAL TRIAL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
T LYMPHOCYTE SUBPOPULATION;
VIRUS PATHOGENESIS;
VIRUS REPLICATION;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HIV;
HIV INFECTIONS;
HUMANS;
LYMPHOID TISSUE;
RNA, VIRAL;
VIREMIA;
VIRUS REPLICATION;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0030057089
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.272.5270.1886 Document Type: Note |
Times cited : (71)
|
References (18)
|